Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antithrombin III in burned children].

D Del Principe1

  • 1Clinica Pediatrica, Università di Roma Tor Vergata, Roma, Italy.

Minerva Anestesiologica
|May 28, 2003
PubMed
Summary
This summary is machine-generated.

Severe burn patients with low Antithrombin III (ATIII) levels face higher mortality. ATIII concentrate infusions improved plasma levels and microcirculation recovery in a pilot study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gender disparity in pediatric diseases.

Current molecular medicine·2013
Same author

Combined thrombolytic therapy for atrial thrombus in a preterm infant.

Minerva pediatrica·2011
Same author

Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease.

Clinical and experimental immunology·2010
Same author

Trans-plasma membrane electron transport in human blood platelets.

Mini reviews in medicinal chemistry·2008
Same author

Non-classical antileukemia activity of early recovering NK cells after induction chemotherapy and HLA-identical stem cell transplantation in myeloid leukemias.

Leukemia·2006
Same author

Involvement of oxygen radicals in cytarabine-induced apoptosis in human polymorphonuclear cells.

Biochemical pharmacology·2001

Area of Science:

  • Biomedical research
  • Trauma surgery
  • Critical care medicine

Background:

  • Severe burns significantly impact hemostatic parameters and Antithrombin III (ATIII) levels.
  • Understanding these changes is crucial for predicting survival and guiding treatment in pediatric burn patients.

Purpose of the Study:

  • To investigate the relationship between haemostatic parameters, specifically Antithrombin III (ATIII) levels, and survival in severe burn patients.
  • To evaluate the safety and efficacy of Antithrombin III (ATIII) concentrate infusions in improving outcomes for thermal injury patients.

Main Methods:

  • Analysis of haemostatic parameters and ATIII levels in 50 pediatric severe burn admissions using statistical methods (Fisher exact test, chi square, logistic regression, discriminant analysis).
  • A pilot study involving ATIII concentrate infusions every 8 hours for 72 hours in burn patients, compared to a control group.

Related Experiment Videos

Main Results:

  • Total burned surface area was the best predictor of survival. ATIII levels showed a significant correlation with mortality (p=0.0005).
  • ATIII concentrate infusions successfully raised plasma ATIII levels to 105%+/-20% compared to 50%+/-14% in controls (P < 0.001).
  • Patients treated with ATIII concentrate experienced shorter microcirculation recovery times (P<0.02).

Conclusions:

  • Low Antithrombin III (ATIII) levels are a significant predictor of mortality in severe burn patients.
  • Antithrombin III (ATIII) concentrate infusions appear safe and effective in improving plasma levels and accelerating microcirculation recovery in thermal injury.
  • Further research into ATIII management in burn care is warranted.